IFNG and myeloid sarcoma: These events may be associated with the transition of the immune system towards inflammation, which leads to the subsequent production of IFN-γ and IL-17A in T cells, responsible for the differentiation and activation of Th1 and Th17, maintaining the chronic inflammation that can be seen in MS.